Twenty-Four Hour Blood Pressure Response to Empagliflozin and Its Determinants in Normotensive Non-diabetic Subjects

BACKGROUND: Sodium–glucose co-transport 2 inhibitors (SGLT2i) lower blood pressure (BP) in normotensive subjects and in hypertensive and normotensive diabetic and non-diabetic patients. However, the mechanisms of these BP changes are not fully understood. Therefore, we examined the clinical and bioc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zanchi, Anne, Pruijm, Menno, Muller, Marie-Eve, Ghajarzadeh-Wurzner, Arlène, Maillard, Marc, Dufour, Nathalie, Bonny, Olivier, Wuerzner, Grégoire, Burnier, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981729/
https://www.ncbi.nlm.nih.gov/pubmed/35391843
http://dx.doi.org/10.3389/fcvm.2022.854230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981729/
https://www.ncbi.nlm.nih.gov/pubmed/35391843
http://dx.doi.org/10.3389/fcvm.2022.854230

Ejemplares similares